Reply: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma

被引：0
|
作者：
Sharma, Vidit [1 ]
机构：
[1] Dept Urol, Mayo Clin, 200 1st St SW, Rochester, MN 55901 USA
来源：
JOURNAL OF UROLOGY | 2024年 / 212卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000004136
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：621 / 622
页数：2
相关论文
共 50 条
  • [1] Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma
    Zganjar, Andrew
    Khanna, Abhinav
    Joyce, Dan
    Nichols, Paige
    Britton, Cameron
    Lohse, Christine M.
    Cheville, John C.
    Gupta, Sounak
    Potretzke, Aaron M.
    Thompson, R. Houston
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    Sharma, Vidit
    JOURNAL OF UROLOGY, 2024, 212 (02): : 331 - 341
  • [2] Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma
    Longoni, Mattia
    Rosiello, Giuseppe
    Larcher, Alessandro
    Montorsi, Francesco
    Capitanio, Umberto
    JOURNAL OF UROLOGY, 2024, 212 (04):
  • [3] MAYO CLINIC VALIDATION OF THE AMERICAN UROLOGIC ASSOCIATION RISK GROUPS FOR LOCALIZED RENAL CANCER
    Zganjar, Andrew
    Khanna, Abhinav
    Joyce, Dan
    Nichols, Paige
    Lohse, Christine
    Cheville, John
    Gupta, Sounak
    Potretzke, Aaron
    Thompson, R. Houston
    Leibovich, Bradley
    Boorjian, Stephen
    Sharma, Vidit
    JOURNAL OF UROLOGY, 2022, 207 (05): : E809 - E810
  • [4] External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma
    Fujii, Yasuhisa
    Saito, Kazutaka
    Iimura, Yasumasa
    Sakai, Yasuyuki
    Koga, Fumitaka
    Kawakami, Satoru
    Kumagai, Jiro
    Kihara, Kazunori
    JOURNAL OF UROLOGY, 2008, 180 (04): : 1290 - 1295
  • [5] Outcomes of patients with sarcomatoid renal cell carcinoma: The Mayo Clinic experience
    Costello, Brian Addis
    Zhang, Ben
    Lohse, Christine M.
    Boorjian, Stephen A.
    Cheville, John
    Leibovich, Bradley C.
    Thompson, Robert Houston
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival REPLY
    Thiel, David D.
    Davidiuk, Andrew J.
    Meschia, Camille
    Serie, Daniel
    Custer, Kaitlynn
    Petrou, Steven P.
    Parker, Alexander S.
    UROLOGY, 2016, 89 : 61 - 62
  • [7] External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma - Editorial comment
    Pavlovich, Christian P.
    JOURNAL OF UROLOGY, 2008, 180 (04): : 1295 - 1296
  • [8] Reply to Editorial Comment on "Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma"
    Britton, Cameron J.
    Potretzke, Aaron M.
    UROLOGY, 2024, 194 : 145 - 145
  • [9] EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS
    Lorentz, Adam
    Tai, Caroline
    Capitanio, Umberto
    Carballido, Joaquin
    Ciancio, Gaetano
    Daneshmand, Siamak
    Evans, Christopher
    Gontero, Paolo
    Haferkamp, Axel
    Hohenfellner, Markus
    Huang, William
    Linares Espinos, Estefania
    Martinez-Salamanca, Juan
    McKiernan, James
    Montorsi, Francesco
    Pahernik, Sascha
    Palou, Juan
    Pruthi, Raj
    Russo, Paul
    Scherr, Douglas
    Spahn, Martin
    Terrone, Carlo
    Tilki, Derya
    Vera-Donoso, Cesar
    Vergho, Daniel
    Wallen, Eric
    Zigeuner, Richard
    Libertino, John
    Master, Viraj
    JOURNAL OF UROLOGY, 2017, 197 (04): : E66 - E67
  • [10] THE 'LEIBOVICH' - MAYO CLINIC SCORING ALGORITHM FOR CLEAR CELL RENAL CELL CARCINOMA SUPPLEMENTED BY VASCULAR INVASION
    Chromecki, T.
    Hutterer, G. C.
    Imamovic, A.
    Kampel-Kettner, K.
    Rehak, P.
    Langner, C.
    Pummer, K.
    Zigeuner, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 154 - 154
12345